CLINICAL_TRIALS
trial_result
· 2021-12-07
Clinical Trial Update: Selinexor in Advanced Liposarcoma [Phase 2, Phase 3]
Summary
Phase 2/3 trial of selinexor in dedifferentiated liposarcoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karyopharm Therapeutics Inc | Conditions: Dedifferentiated Liposarcoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-12-07